AstraZeneca (AZNL)

12,377.00p
   
  • Change Today:
    -0.84p
  • 52 Week High: 12,880.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 157,298
  • Market Cap: £156,465m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-25 Interim 28,045.00 6,529.00 346.00¢ 103.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 39.5 0.3 +137% 280.00¢ 2.9%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,420.5 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 69.6 0.0 +2,550% 290.00¢ 2.0%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.1 0.1 +242% 290.00¢ 2.1%
31-Dec-24 54,073.00 8,691.00 821.00¢ 16.7 1.3 +13% 310.00¢ 2.3%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 58,156.23 18,325.18 689.99p 17.9 1.7 +10% 246.16p 0.0%
31-Dec-26 61,658.65 20,932.87 782.90p 15.8 1.2 +14% 259.17p 0.0%
31-Dec-27 65,231.66 22,837.05 872.53p 14.2 1.2 +11% 269.92p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.06

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,377.00p
Change Today -0.84p
% Change -0.67 %
52 Week High 12,880.00p
52 Week Low 9,642.00p
Volume 157,298
Shares Issued 1,264.16m
Market Cap £156,465m

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 03-Nov-2025

Time Volume / Share Price
16:29 5 @ 12,378.00p
16:29 82 @ 12,378.00p
16:29 140 @ 12,378.00p
16:29 19 @ 12,378.00p
16:29 30 @ 12,378.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page